RKR Radiology Reporting Ltd 12089606 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is specialists medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 12089606 2023-04-01 2024-03-31 12089606 2024-03-31 12089606 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 12089606 1 2024-03-31 12089606 bus:Micro-entities 2023-04-01 2024-03-31 12089606 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 12089606 bus:FilletedAccounts 2023-04-01 2024-03-31 12089606 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 12089606 bus:RegisteredOffice 2023-04-01 2024-03-31 12089606 bus:Director1 2023-04-01 2024-03-31 12089606 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 12089606 countries:EnglandWales 2023-04-01 2024-03-31 12089606 1 2023-04-01 2024-03-31 12089606 1 2023-03-31 12089606 2022-04-01 2023-03-31 12089606 2023-03-31 12089606 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 12089606 1 2023-03-31 12089606 1 2022-04-01 2023-03-31 12089606 1 2022-03-31 iso4217:GBP xbrli:pure

Registration number: 12089606

RKR Radiology Reporting Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2024

 

RKR Radiology Reporting Ltd

Contents

Statement of Financial Position

1 to 2

Notes to the Unaudited Financial Statements

1

 

RKR Radiology Reporting Ltd

(Registration number: 12089606)
Statement of Financial Position as at 31 March 2024

2024
£

2023
£

Fixed assets

203

90

Current assets

3,081

6,541

Creditors: Amounts falling due within one year

(467)

(967)

Net current assets

2,614

5,574

Total assets less current liabilities

2,817

5,664

Accruals and deferred income

(540)

(1,194)

 

2,277

4,470

Capital and reserves

2,277

4,470

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Plym House
3 Longbridge Road
Plymouth
Devon
PL6 8LT

Principal activity

The principal activity of the company is specialists medical practice activities

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The financial statements are prepared in sterling which is the functional currency of the entity.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2023 - 1).

3

Related party transactions

Transactions with the director

2024

At 1 April 2023
£

Advances to director
£

Repayments by director
£

At 31 March 2024
£

Director

(568)

(467)

568

(467)

         
       

 

 

RKR Radiology Reporting Ltd

(Registration number: 12089606)
Statement of Financial Position as at 31 March 2024 (continued)

3

Related party transactions (continued)

2023

At 1 April 2022
£

Advances to director
£

Repayments by director
£

At 31 March 2023
£

Director

(419)

(568)

419

(568)

         
       

 

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Statement of Comprehensive Income.

Approved and authorised by the director on 15 August 2024
 


Dr R D Riordan
Director